Rigel PharmaceuticalsRIGL
13F holders, Q2 2026 (June 30)1holders −8
0new positions
8sold out
$1.00avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Rigel Pharmaceuticals Inc. (RIGL) in their 13F filings, down 8 from Q1 2026. 0 opened new positions and 8 sold out. The largest holder was Huntington National Bank ($1).
- Company
- Rigel Pharmaceuticals Inc.
- CUSIP
- 766559603
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 8 | $90K |
All 13F filers, Q1 2026 → Q2 2026: 3,324 shares sold, net −3,324 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Huntington National Bank | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is RIGL's weight in each manager's 13F, not the share of Rigel Pharmaceuticals Inc. the manager owns.